A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...
New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either ...
RemeGen’s Phase III trial of disitamab vedotin shows improved progression-free survival in advanced breast cancer patients ...
On the morning of2, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) ...
Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback